116349004: Gatifloxacin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with antibacterial mechanism of action (substance)\Quinolone antibacterial\Fluoroquinolone (substance)\Gatifloxacin

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Quinolone (substance)\Quinolone antibacterial\Fluoroquinolone (substance)\Gatifloxacin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Gatifloxacin	Is a	Medicinal product containing quinolone and acting as antibacterial agent (product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Gatifloxacin	Is a	Quinolone antibacterial	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Gatifloxacin	Has disposition	Antibacterial (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Gatifloxacin	Is a	Fluoroquinolone (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Gatifloxacin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Gatifloxacin 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Gatifloxacin 10mg/mL injection solution 20mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Gatifloxacin 2mg/mL infusion solution 100mL bag	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Gatifloxacin 2mg/mL infusion 200mL bag (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Gatifloxacin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Gatifloxacin 200mg/vial solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Gatifloxacin 400mg/vial solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Gatifloxacin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Gatifloxacin-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Zymar	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Zymar 0.3% ophthalmic solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely gatifloxacin 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing gatifloxacin in ophthalmic dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Gatifloxacin 5 mg/mL eye solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)
Gatifloxacin 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Gatifloxacin 400 mg oral tablet	Has basis of strength substance (attribute)	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Gatifloxacin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Gatifloxacin 200 mg oral tablet	Has basis of strength substance (attribute)	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Gatifloxacin 200 mg oral tablet	Has precise active ingredient	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Gatifloxacin 400 mg oral tablet	Has precise active ingredient	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing gatifloxacin in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Gatifloxacin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only gatifloxacin in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Gatifloxacin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Gatifloxacin only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug)	Has basis of strength substance (attribute)	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug)	Has precise active ingredient	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Gatifloxacin 5 mg/mL eye solution	Has basis of strength substance (attribute)	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Gatifloxacin 5 mg/mL eye solution	Has precise active ingredient	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely gatifloxacin 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has basis of strength substance (attribute)	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely gatifloxacin 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has precise active ingredient	True	Gatifloxacin	Inferred relationship	Existential restriction modifier (core metadata concept)	1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
177274013	Gatifloxacin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
677592014	Gatifloxacin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
177274013	Gatifloxacin	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
177274013	Gatifloxacin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
677592014	Gatifloxacin (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
677592014	Gatifloxacin (substance)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
677592014	Gatifloxacin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4756961000241117	gatifloxacine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
4756961000241117	gatifloxacine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module